4-Acetylantroquinonol B inhibits lipopolysaccharide-induced cytokine release and alleviates sepsis through of MAPK and NFκB suppression.
Chien-Hsin ChangChun-Chieh HsuAn-Sheng LeeShih-Wei WangKung-Tin LinWei-Luen ChangHui-Chin PengWen-Chiung HuangChing-Hu ChungPublished in: BMC complementary and alternative medicine (2018)
These results showed that 4AAQB exhibited anti-inflammatory property both in vitro and in vivo, suggesting that 4AAQB may be a therapeutic candidate which used in inflammatory disorders treatment.